👁️
Ophthalmology
Eye disease treatments including gene therapies for inherited retinal diseases, anti-VEGF agents, and glaucoma therapies.
Companies
0
Pipeline Drugs
313
Key People
580
Ophthalmology Pipeline (313 drugs)
Approved: 73Phase 3: 39Preclinical: 24Phase 2: 20Phase 1: 19Phase 1/2: 15Approved/Commercial: 14Pre-clinical: 13Pending Approval: 12Early Phase: 9Discovery: 9Commercial: 6Pre-clinical to Commercial: 6Phase 2/3: 5Pre-clinical / Clinical: 5Research: 4Phase 2b: 3Discovery/Preclinical: 3Registrational: 2Proof of Concept: 2Phase 2a: 2Preclinical/Phase 1: 2IND Planned: 2Phase 1/2a: 2Preclinical/Discovery: 2ANDA Filed/Approved: 2ANDA Filed/Development: 2Various: 1Filed: 1Preclinical/Research: 1Research/Discovery: 1Phase 2b/3: 1Phase 1b: 1Submitted: 1IND Cleared: 1Research to Commercial: 1Phase 3 (likely): 1Phase 1/Phase 2 (implied): 1Preclinical / Phase 1: 1Approved (China NMPA Review): 1Clinical Stage: 1Phase 1b/2a: 1Pre-Clinical: 1
| Drug | Company | Indication | Phase |
|---|---|---|---|
| EYLEA (aflibercept) | Regeneron Pharmaceuticals | Wet AMD, diabetic macular edema, retinal vein occlusion | Approved |
| Dupixent (dupilumab) | Regeneron Pharmaceuticals | Atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyposis | Approved |
| Libtayo (cemiplimab) | Regeneron Pharmaceuticals | Cutaneous squamous cell carcinoma, basal cell carcinoma, NSCLC | Approved |
| Praluent (alirocumab) | Regeneron Pharmaceuticals | High cholesterol | Approved |
| Kevzara (sarilumab) | Regeneron Pharmaceuticals | Rheumatoid arthritis | Approved |
| Evkeeza (evinacumab) | Regeneron Pharmaceuticals | Homozygous familial hypercholesterolemia | Approved |
| EYLEA HD | Regeneron Pharmaceuticals | Wet AMD, diabetic macular edema | Phase 3 |
| Dupixent | Regeneron Pharmaceuticals | COPD | Phase 3 |
| REGN5458 | Regeneron Pharmaceuticals | Multiple myeloma | Phase 1/2 |
| REGN4018 | Regeneron Pharmaceuticals | MUC16-expressing cancers | Phase 1/2 |
| Pozelimab | Regeneron Pharmaceuticals | Complement-mediated diseases | Phase 2/3 |
| Ilumya (tildrakizumab) | Sun Pharmaceutical | Psoriasis | Approved |
| CEQUA (cyclosporine) | Sun Pharmaceutical | Dry Eye Disease | Approved |
| Absorica/Absorica LD | Sun Pharmaceutical | Severe Acne | Approved |
| Levulan Kerastick | Sun Pharmaceutical | Actinic Keratosis | Approved |
| Biosimilar Portfolio | Sun Pharmaceutical | Various Oncology/Autoimmune | Phase 3 |
| SCD-044 | Sun Pharmaceutical | Psoriasis | Phase 2 |
| Generic Pipeline | Sun Pharmaceutical | Multiple | Various |
| Xarelto (rivaroxaban) | Bayer | Anticoagulation | Approved |
| Nexavar (sorafenib) | Bayer | Hepatocellular carcinoma, Renal cell carcinoma | Approved |
| Stivarga (regorafenib) | Bayer | Colorectal cancer, GIST | Approved |
| Vitrakvi (larotrectinib) | Bayer | TRK fusion cancers | Approved |
| Nubeqa (darolutamide) | Bayer | Prostate cancer | Approved |
| Kerendia (finerenone) | Bayer | Diabetic kidney disease | Approved |
| BAY 1817080 | Bayer | Multiple solid tumors | Phase 1 |
| BAY 1895344 | Bayer | Advanced solid tumors | Phase 1 |
| BAY 2927088 | Bayer | Solid tumors | Phase 1 |
| Brepocitinib | Roivant Sciences | Dermatomyositis | Registrational |
| IMVT-1402 | Roivant Sciences | Graves' Disease | Registrational |
| Batoclimab | Roivant Sciences | Thyroid Eye Disease | Proof of Concept |
| Mosliciguat | Roivant Sciences | Pulmonary Hypertension associated with Interstitial Lung Disease | Proof of Concept |
| VTAMA (tapinarof) | Roivant Sciences | Plaque Psoriasis | Commercial |
| Tinlarebant (LBS-008) | Belite Bio | Geographic Atrophy (Dry AMD) | Phase 3 |
| LBS-009 | Belite Bio | Non-Fatty Liver Disease | Preclinical |
| iStent inject W with Infinite Injector Technology | Glaukos | Mild to moderate primary open-angle glaucoma with cataract surgery | Approved |
| iStent infinite | Glaukos | Primary open-angle glaucoma (failed prior surgical intervention) | Approved |
| iLink V Corneal Cross-linking System | Glaukos | Progressive keratoconus | Approved |
| Epioxa | Glaukos | Undisclosed ophthalmic indication | Approved |
| VibeX Rapid | Glaukos | Corneal cross-linking (riboflavin solution) | Approved |
| Sustained-release drug delivery platforms | Glaukos | Retinal diseases | Pre-clinical |
| Brekiya (dihydroergotamine mesylate) | Amneal Pharmaceuticals | Acute Treatment of Migraine & Cluster Headache | Approved |
| CREXONT (Carbidopa/Levodopa) | Amneal Pharmaceuticals | Parkinson's Disease | Approved |
| Mesalamine DR | Amneal Pharmaceuticals | Gastroenterology (Ulcerative Colitis) | Approved |
| Everolimus | Amneal Pharmaceuticals | Oncology | Approved |
| Epinephrine (Adrenalin generic) | Amneal Pharmaceuticals | Emergency/Critical Care | Pending Approval |
| Prednisolone acetate | Amneal Pharmaceuticals | Ophthalmology | Approved |
| Risperidone ER | Amneal Pharmaceuticals | Psychiatry | Approved |
| Iohexol (Omnipaque generic) | Amneal Pharmaceuticals | Diagnostic Imaging | Pending Approval |
| Eltrombopag (Promacta generic) | Amneal Pharmaceuticals | Hematology | Pending Approval |
| Lanreotide injection | Amneal Pharmaceuticals | Oncology (NETs, Acromegaly) | Pending Approval |
Key People in Ophthalmology
LS
Leonard Schleifer
Co-Founder, President and Chief Executive Officer
Regeneron Pharmaceuticals
GY
George Yancopoulos
Co-Founder, President and Chief Scientific Officer
Regeneron Pharmaceuticals
RL
Robert Landry
Executive Vice President and Chief Financial Officer
Regeneron Pharmaceuticals
MM
Marion McCourt
Executive Vice President, Commercial
Regeneron Pharmaceuticals
IL
Israel Lowy
Executive Vice President, Chief Medical Officer
Regeneron Pharmaceuticals
DV
Daniel Van Plew
Executive Vice President, General Counsel
Regeneron Pharmaceuticals
CF
Christopher Fenimore
Vice President, Investor Relations
Regeneron Pharmaceuticals
RC
Ryan Crowe
Executive Vice President, Chief Business Officer
Regeneron Pharmaceuticals
DS
Dilip Shanghvi
Managing Director and Founder
Sun Pharmaceutical
AS
Aalok Shanghvi
Executive Director
Sun Pharmaceutical
CM
C.S. Muralidharan
Chief Financial Officer
Sun Pharmaceutical
KG
Kirti Ganorkar
CEO - India Business
Sun Pharmaceutical
AG
Abhay Gandhi
CEO - North America
Sun Pharmaceutical
AP
Aditya Pinto
Executive Vice President - International Business
Sun Pharmaceutical
WB
Werner Baumann
CEO
Bayer